Nov 2022
$57.6 Million
G1 Therapeutics
Sep 2018
$207 Million
G1 Therapeutics
Jun 2018
$125 Million
G1 Therapeutics
Mar 2018
$115 Million
G1 Therapeutics
May 2017
$105 Million
G1 Therapeutics
Our primary goals as an organization are achieved through adhering to our core values of vision, empathy, sustainability and tenacious teamwork in pursuit of our clients’ interests.